Accueil

Umifenovir

Umifenovir

Spécifications

131707-25-0Numéro CAS
814-571-6Numéro CE
ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylateNom IUPAC
C22H25BrN2O3SFormule chimique
477.4 g/molMasse molaire
umifenovir; 131707-25-0; ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate; 93M09WW4RU; ethyl 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate; 1H-Indole-3-carboxylic acid, 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-, ethyl ester; DTXSID60895015; 1H-Indole-3-carboxylic acid, 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-, ethyl ester; Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate; arbidole; umifenovirum; ethyl 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate; RefChem:900994; J05AX13; DTXCID401324574; 1-methyl-2-((phenylthio)methyl)-3-carbethoxy-4-((dimethylamino)methyl)-5-hydroxy-6-bromoindole; Umifenovir [INN]; ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate; MFCD01326495; MLS000777586; Umifenovir (INN); SMR000413980; C22H25BrN2O3S; 1H-indole-3-carboxylic acid, 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-, ethyl ester, hydrochloride; UNII-93M09WW4RU; 6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylic Acid Ethyl Ester; 6-Bromo-4-dimethylaminomethyl-5-hydroxy-1-methyl-2-phenylsulfanylmethyl-1H-indole-3-carboxylic acid ethyl ester; 75U; ETHYL 6-BROMO-4-((DIMETHYLAMINO)METHYL)-5-HYDROXY-1-METHYL-2-((PHENYLSULFANYL)METHYL)-1H-INDOLE-3-CARBOXYLATE; Arbidol; Umifenovir; AR-1I9514; Umifenovir (Standard); ChemDiv1_000732; UMIFENOVIR [WHO-DD]; Oprea1_384852; Oprea1_482224; MLS006011808; cid_131411; orb1685431; orb2900414; SCHEMBL1068701; CHEMBL1214598; BDBM83797; GTPL11089; HMS589B06; CHEBI:134730; KCFYEAOKVJSACF-UHFFFAOYSA-N; HMS2760J21; ALBB-028966; EX-A3050; HY-14904R; STK021887; AKOS001485435; AT13213; DB13609; DT-0014; FA17969; NCGC00246387-01; NCGC00246387-02; NCGC00246387-06; NCGC00246387-09; AU176627; DA-71019; ethyl 6-bromo-4-(dimethylaminomethyl)-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate; HY-14904; ST025095; CS-0003625; NS00071612; T7911; D10558; AB00644670_06; F600385; BRD-K73881242-003-02-0; BRD-K73881242-003-03-8; BRD-K73881242-003-04-6; Q27271599; 1-METHYL-2-((PHENYLTHIO)METHYL)-3-CARBETHOXY-4-((DIMETHYLAMINO)METHYL)-5-HYDROXY-6-BROMINDOLE; 5674-91-9; 6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-,Arbidol hydrochloride; 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-3-indolecarboxylic acid ethyl ester; 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]indole-3-carboxylic acid ethyl ester; 6-Bromo-4-dimethylaminomethyl-5-hydroxy-1-methyl-2-phenylsulfanylmethyl-1H-indole-3-carboxylic acid ethyl ester; 6-Bromo-5-hydroxy-4-methylaminomethyl-1-methyl-2-benzenesulfenylmethylindole-3-ethyl carboxylate; ethyl 4-[(dimethylamino)methyl]-6-bromo-5-hydroxy-1-methyl-2-(phenylthiomethyl )indole-3-carboxylate; ethyl 6-bromanyl-4-[(dimethylamino)methyl]-1-methyl-5-oxidanyl-2-(phenylsulfanylmethyl)indole-3-carboxylate; ethyl 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxilateSynonymes